Immunologic correlates of the abscopal effect in a patient with melanoma

New England Journal of Medicine

Volumn 366, Issue 10, 2012, Pages 925-931

  Postow, Michael A ^a,e   Callahan, Margaret K ^a,e   Barker, Christopher A ^a,e   Yamada, Yoshiya ^a,e   Yuan, Jianda ^a   Kitano, Shigehisa ^a   Mu, Zhenyu ^a   Rasalan, Teresa ^a   Adamow, Matthew ^a   Ritter, Erika ^c   Sedrak, Christine ^c   Jungbluth, Achim A ^c   Chua, Ramon ^c   Yang, Arvin S ^f   Roman, Ruth Ann ^b   Rosner, Samuel ^d   Benson, Brenna ^g   Allison, James P ^a,e   Lesokhin, Alexander M ^a,e   Gnjatic, Sacha ^c   Wolchok, Jedd D ^a,c,e   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c STONY BROOK UNIVERSITY   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f Department of Environmental and Radiological Health Sciences   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CISPLATIN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; INDUCIBLE T CELL COSTIMULATOR; IPILIMUMAB; NY ESO 1 ANTIGEN; PROTEIN ANTIBODY; TEMOZOLOMIDE; VINBLASTINE;

ADULT; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOLOGY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; IMMUNOSTIMULATION; INTENSITY MODULATED RADIATION THERAPY; LOCAL EXCISION; LUNG LOBECTOMY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAINTENANCE THERAPY; MELANOMA; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SPINE METASTASIS; SPLEEN INJURY; T LYMPHOCYTE ACTIVATION; THORAX RADIOGRAPHY;

EID: 84857815877     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1112824     Document Type: Article

References (25)

1. Mole RH. Whole body irradiation: radiobiology or medicine? Br J Radiol 1953; 26:234-41.
2. Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol 1975;48:863-6.
3. Robin HI, AuBuchon J, Varanasi VR, Weinstein AB. The abscopal effect: demonstration in lymphomatous involvement of kidneys. Med Pediatr Oncol 1981;9:473-6. (Pubitemid 12245882)
4. Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner KM, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol 2006;45: 493-7. (Pubitemid 43884622)
5. Drake C. Radiation-induced immune modulation. In: DeWeese TL, Laiho M, eds. Molecular determinants of radiation response. New York: Springer, 2011:251-63.
6. Jungbluth AA, Chen YT, Stockert E, et al. Immunohistochemical analysis of NYESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856-60. (Pubitemid 32467376)
7. Yuan J, Adamow M, Ginsberg BA, et al. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A 2011;108:16723-8.
8. Carthon BC, Wolchok JD, Yuan J, et al. Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial. Clin Cancer Res 2010;16:2861-71.
9. Filipazzi P, Valenti R, Huber V, et al. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol 2007;25:2546-53. (Pubitemid 47041228)
10. Lesokhin A, Hohl TM, Kitano S, et al. Monocytic CCR2+ myeloid derived suppressor cells promote immune escape by limiting activated CD8 T cell infiltration into the tumor microenvironment. Cancer Res 2011 December 15 (Epub ahead of print).
11. Gnjatic S, Wheeler C, Ebner M, et al. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. J Immunol Methods 2009; 341:50-8.
12. Wolchok JD, Hoos A, O'Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immunerelated response criteria. Clin Cancer Res 2009;15:7412-20.
13. Jungbluth AA, Chen YT, Stockert E, et al. Immunohistochemical analysis of NYE-SO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856-60. [Erratum, Int J Cancer 2002;97:878.] (Pubitemid 32467376)
14. Gnjatic S, Old LJ, Chen YT. Autoantibodies against cancer antigens. Methods Mol Biol 2009;520:11-9.
15. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23. [Erratum, N Engl J Med 2010;363:1290.]
16. Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 2011;364:2517-26.
17. Chakravarty PK, Alfieri A, Thomas EK, et al. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res 1999;59:6028-32. (Pubitemid 30035614)
18. Demaria S, Ng B, Devitt ML, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 2004;58:862-70. (Pubitemid 38221143)
19. Demaria S, Kawashima N, Yang AM, et al. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res 2005;11:728-34. (Pubitemid 40116901)
20. Dewan MZ, Galloway AE, Kawashima N, et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009;15:5379-88.
21. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004;21:137-48. (Pubitemid 39094044)
22. Jager E, Stockert E, Zidianakis Z, et al. Humoral immune responses of cancer patients against "Cancer-Testis" antigen NYE-SO-1: correlation with clinical events. Int J Cancer 1999;84:506-10.
23. Zhang B, Bowerman NA, Salama JK, et al. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J Exp Med 2007;204:49-55. (Pubitemid 46148755)
24. Kahana O, Micksche M, Witz IP, Yron I. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma. Oncogene 2002;21:3969-77. (Pubitemid 34679238)
25. Scanlan MJ, Gordan JD, Williamson B, et al. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 1999;83:456-64. (Pubitemid 29489858)